Six Lawsuits Filed Against Humira Maker
Pharma Company Accused of Using Legal Tricks to Squash Generic Version Last October, we wrote about the tactics used by pharma company AbbVie to artificially extend its patents on its billion-dollar drug Humira. Now six groups are filing lawsuits against AbbVie for “anticompetitive conduct.” Humira is a rheumatoid-arthritis and gut-disorders drug that enjoys sales of …